Trials
Regulations
Contact Us

Welcome to pediculosis.com

Pediculosis.com is the world's only website aimed specifically at researchers, product managers and buyers in the head lice industry.

We provide regularly-updated information on new products, industry changes, regulatory issues, clinical trials and studies to help you identify emerging global trends and business opportunities.

btn-readmore

Hatchtech Pty Ltd this week announced successful results for its phase 3 trials of Xeglyze™ Lotion, a novel lice and egg treatment.

The studies comprised 704 subjects receiving a single ten-minute application of Xeglyze™ Lotion, resulting in 81.5% of subjects remaining lice free through to the 14-day follow-up point. This represents a statistically significant increase in anti-lice treatment versus the control.

There were few adverse effects reported, and none were serious in nature.

The active ingredient of Xeglyze™ Lotion is known to inhibit key pathways in the life cycle of the head louse, including the egg, supported by both published results and patent information.

Hatchtech intend to file a New Drug Application with the US Food and Drug Administration in 2015.

  • Regulatory News
  • Pediculosis.com: The world's only specialist website for the head lice industry
  • Licecomb Engineering
  • Scientific News
  • Company News

Join us on Twitter

Site Map   |    Privacy Policy   |   Terms & Conditions

© 2012-2013 pediculosis.com — all rights reserved